U.S. Stocks on the Move-Kamada, Mitek, Stereotaxis, Shoe Carnival

Stereotaxis

04/09/2014 15:12

(For faster updates on individual market-movers, Eikon users 
please use search string "STXBZ US"; for more market insights, 
including options activity,  STXNEWS/US ; for the Day Ahead 
newsletter, http://link.reuters.com/mex49s; for the Morning News 
Call newsletter, http://link.reuters.com/nex49s) 
     
     U.S. stocks opened slightly higher on Thursday, after the 
European Central Bank cut interest rates to record lows and a 
flurry of economic data indicated the U.S. economy was steadily 
improving. The Dow Jones industrial average  .DJI  was up 0.37 
percent at 17,141.44, the S&P 500  .SPX  was up 0.40 percent at 
2,008.66 and the Nasdaq Composite  .IXIC  was up 0.2 percent 
4,581.71.  .N  
     
    ** SHOE CARNIVAL INC  SCVL.O , $19.635, -11.39 pct 
    The footwear retailer reported lower-than-expected second 
quarter sales and profit as fewer customers visited its stores 
and expenses rose. Its profit has now missed estimates for the 
last three quarters. The company forecast third quarter 
comparable-store sales to either decline up to 1 percent or grow 
up to 1 percent. 
    Susquehanna Financial Group analysts cut price target to $24 
from $25 on the stock which had fallen 24 percent this year up 
to Wednesday's close.  ID:nL3N0R53OJ  
     
    ** SOLARCITY CORP  SCTY.O , $71.3, +5.29 pct 
    The solar panel installer said it would open 20 new 
operations centres in seven U.S. states. The company, backed by 
Tesla Motors Inc  TSLA.O  founder Elon Musk, says new centers 
expected to create more than 600 additional jobs. 
 ID:nGNXVBLRLa  
 
    ** BAZAARVOICE INC  BV.O , $8.09, +7.87 pct  
    B. Riley & Co raises price target on stock of the software 
maker to $10 from $9.75, saying net new client additions in Q1 
were significantly higher than it had estimated. 
    Bazaarvoice, which provides businesses online and social 
media tools to interact with customers, reported 
higher-than-expected Q1 revenue and smaller-than-expected loss 
on Wednesday  ID:nGNXVBLJAa  
     
    ** VERIFONE SYSTEMS INC  PAY.N , $35.93, +4.02 pct 
    The credit card swipe machine maker raised full-year revenue 
forecast for the third time, encouraged by strong sales of 
devices that can accept chip-embedded credit cards. VeriFone 
also raised full-year profit forecast and reported 
better-than-expected third quarter revenue. 
    The company is benefiting as U.S. retailers upgrade their 
point-of-sale terminals to systems compatible with more secure 
credit cards in the wake of several data breaches. Up to 
Wednesday's close, the stock had risen nearly 30 percent this 
year.  ID:nL3N0R53ZX  
     
    ** ARLINGTON ASSET INVESTMENT CORP  AI.N , $27.14, -4.40 pct 
    The mortgage investor said it was offering 2.75 million 
shares of Class A common stock - 14 percent of its total 
outstanding shares - at $27.61 each, a 2.7 pct discount to 
Wednesday's close.  ID:nPn5dRH4M  
    Arlington said it plans to use the proceeds to acquire 
assets. Up to Wednesday's close, the stock had risen 7.6 percent 
this year. 
     
    ** STEREOTAXIS INC  STXS.O ,$3.31, +16.14 pct 
    The medical device maker received U.S. FDA's marketing 
approval for its device used during procedures to assess heart 
activity. The device, called Vdrive Robotic Navigation System, 
is designed to remotely control catheter during such procedures. 
 ID:nGNXVBLOIa  
     
    ** KAMADA LTD  KMDA.O , $5.6, -21.79 pct 
    The Israel-based drugmaker's experimental drug to treat an 
inherited condition that raises the risk of lung and liver 
disease failed in a mid-stage study. The drug, Inhaled Alpha-1 
Antitrypsin, did not show a statistically significant 
difference, compared with a placebo. Glassia, an intravenous 
version of the drug, is already being marketed by Baxter Inc 
 BAX.N  in the United States.  ID:nBw1fT2VCa  
         
    ** CIENA CORP  CIEN.N , $19.13, -6.50 pct 
    The network equipment forecast fourth quarter revenue of 
$570 million-$610 million, below the average analyst estimate of 
$628.9 million. The company said it expects fourth quarter 
adjusted gross margin in the high 30s to low 40s percent range. 
 ID:nBw82Yldha  
     
    ** MITEK SYSTEMS INC  MITK.O , $3.46, +45.99 pct 
    The mobile imaging software maker agreed on Wednesday to 
settle all pending litigation with financial services group USAA 
over five of its patents relating to image capture on mobile 
devices. Mitek's lawsuit filed in 2012 also included allegations 
of misappropriation of trade secrets, breach of contract and 
fraud. The company said neither party will make any payment or 
admit liability on any claims.  ID:nGNXVBLNZa  
     
    ** GOPRO INC  GPRO.O , $54.865, -3.51 pct 
    J.P. Morgan cut its rating on the stock of the maker of  
camera makers to "neutral" from "overweight", saying the stock 
is trading above its price target of $51. The median price 
target on stock is $46.50. Of nine analysts covering the stock, 
2 have "buy" ratings and 7 have "hold" or equivalent ratings. Up 
to Wednesday's close, the stock had risen 137 percent since its 
debut on June 26. 
     
    ** MEMORIAL PRODUCTION PARTNERS LP  MEMP.O , $22.28, -3.80 
pct 
    The oil and gas producer said it would offer 13 million 
common units; representing 18 percent of outstanding shares as 
of Wednesday. The company said it plans to use net proceeds from 
the underwritten public offering to pay down debt. 
     
    ** MATTRESS FIRM HOLDING CORP  MFRM.O , $63.443, +11.68 pct 
    The company said it would buy privately held bedding 
retailer The Sleep Train Inc for $425 million, its sixth and 
largest acquisition announced in the past year, to expand its 
presence on the West Coast.  ID:L3N0R53TS  
     
    ** NEWLINK GENETICS CORP  NLNK.O , $26.73, +2.93 pct 
    NewLink Genetics said the U.S. Food and Drug Administration 
allowed the company to start testing an experimental Ebola 
vaccine in humans. 
    The move follows a decision to begin initial human testing 
of a GlaxoSmithKline  GSK.L  vaccine this month and an approval 
to fast track tests of a Johnson & Johnson  JNJ.N  vaccine. 
 ID:L3N0R53VM  
         
    ** TIBCO SOFTWARE INC  TIBX.O , $22, +4.56 pct 
    The business software maker said it was reviewing its 
strategic and financial alternatives as part of a process 
initiated by its board on Aug. 16 to maximize shareholder value. 
 The company has formed a special committee of independent 
directors to undertake the review. 
     
    ** MATRIX SERVICE CO  MTRX.O , $22.29, -23.48 pct 
    The engineering and construction services provider's fourth 
quarter revenue and profit missed analysts' estimates due to a 
47 percent rise in costs. Revenue from the company's oil, gas 
and chemical segment, which provides construction and 
maintenance services to North American oil producers, fell about 
22 percent to $52.1 million. Matrix also forecast full-year 
earnings below estimates.  ID:nL3N0R45R9  
     
    ** PVH CORP  PVH.N , $127.74, +9.06 pct 
    The apparel company's second quarter profit beat 
expectations, helped by strong sales of its Tommy 
Hilfiger-branded clothes. PVH cut its full-year revenue forecast 
to $8.4 billion from $8.5 billion, but it reaffirmed its profit 
forecast.  ID:nL3N0R45L7  
     
    ** JOY GLOBAL INC  JOY.N , $61.56, -1.03 pct 
    The mining equipment maker posted lower-than-expected 
quarterly revenue and profit and the company narrowed its 
full-year earnings forecast range as coal miners cut spending 
due to weak coal prices amid an oversupply.  ID:nL3N0R53J5  
 
 (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das) 
 ((rohit.kumara@thomsonreuters.com; within U.S. +1 646 223 8780, 
outside U.S. +91 80 6749 1130; Reuters Messaging: 
rohit.kumara.thomsonreuters.com@reuters.net)) 
 
Keywords: MARKETS USA STOCKS/PULSE